EP300 and hepatocellular carcinoma: Notably, treatment of HCC cells with a p300 inhibitor induced a significant decrease in proliferation and sorafenib resistance of HCC cells overexpressing CRNDE, supporting the involvement of epigenetic chromatin relaxation in CRNDE-mediated tumor growth and sorafenib resistance.